u/b12_baseline

amylin receptor distribution is different from GLP-1

"the baseline panel i almost did not bother getting" is the most common sentence of regret and relief on this whole site.

get baseline labs before you start. i will keep saying it in every thread until it stops being necessary, which will be never.

This is the correct method framing. Column and gradient are load-bearing fields.

Titration speed is a side-effect dial far more than an efficacy dial.

My TSH moved faster on tirz than on sema at the same timepoint, which matches what people report.

Not convinced. The evidence does not support that reading.

SURMOUNT data is messier than STEP data but the weight loss is there

stalled on sema, tried tirz, and the curves were actually different shapes

long-running logs are the value

the dual agonism hits different and that is why people describe it differently

week 76 on Mounjaro and the appetite profile is genuinely different from sema

Respectfully this is a sample of one presented as a finding.

Yeah, the chromatogram profile matters more than the headline number.

the appetite change on tirz is more than just reduced hunger, it is different machinery

the 2.4mg dose is not the target, it is just what the pen goes up to

the gradient is doing the separation work, not the column alone

amylin is not a GLP-1, posts conflating them get corrected

the dual agonism hits different and that is why people describe it differently

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

This matches my experience almost exactly on the Ozempic pens. The titration is the whole point.